These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 16814374

  • 1. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.
    Thornton-Jones ZD, Kennett GA, Benwell KR, Revell DF, Misra A, Sellwood DM, Vickers SP, Clifton PG.
    Pharmacol Biochem Behav; 2006 Jun; 84(2):353-9. PubMed ID: 16814374
    [Abstract] [Full Text] [Related]

  • 2. Effects on food intake and blood lipids of cannabinoid receptor 1 antagonist treatment in lean rats.
    Bennetzen MF, Nielsen MP, Richelsen B, Pedersen SB.
    Obesity (Silver Spring); 2008 Nov; 16(11):2451-5. PubMed ID: 18719671
    [Abstract] [Full Text] [Related]

  • 3. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism.
    Cota D, Sandoval DA, Olivieri M, Prodi E, D'Alessio DA, Woods SC, Seeley RJ, Obici S.
    Obesity (Silver Spring); 2009 Aug; 17(8):1641-5. PubMed ID: 19325539
    [Abstract] [Full Text] [Related]

  • 4. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys.
    Wagner JD, Zhang L, Kavanagh K, Ward GM, Chin JE, Hadcock JR, Auerbach BJ, Harwood HJ.
    J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903
    [Abstract] [Full Text] [Related]

  • 5. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats.
    Herling AW, Kilp S, Elvert R, Haschke G, Kramer W.
    Endocrinology; 2008 May; 149(5):2557-66. PubMed ID: 18276749
    [Abstract] [Full Text] [Related]

  • 6. Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet.
    Flamment M, Gueguen N, Wetterwald C, Simard G, Malthièry Y, Ducluzeau PH.
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1162-70. PubMed ID: 19724020
    [Abstract] [Full Text] [Related]

  • 7. Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats.
    Janiak P, Poirier B, Bidouard JP, Cadrouvele C, Pierre F, Gouraud L, Barbosa I, Dedio J, Maffrand JP, Le Fur G, O'Connor S, Herbert JM.
    Kidney Int; 2007 Dec; 72(11):1345-57. PubMed ID: 17882151
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus.
    Rorato R, Miyahara C, Antunes-Rodrigues J, Elias LL.
    Regul Pept; 2013 Mar 10; 182():12-8. PubMed ID: 23327999
    [Abstract] [Full Text] [Related]

  • 10. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I, Sánchez-González C, Martínez R, López-Chaves C, Porres JM, Aranda P, Llopis J, Galisteo M, Zarzuelo A, Errami M, López-Jurado M.
    Metabolism; 2013 Nov 10; 62(11):1641-50. PubMed ID: 23932644
    [Abstract] [Full Text] [Related]

  • 11. Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats.
    Nogueiras R, Veyrat-Durebex C, Suchanek PM, Klein M, Tschöp J, Caldwell C, Woods SC, Wittmann G, Watanabe M, Liposits Z, Fekete C, Reizes O, Rohner-Jeanrenaud F, Tschöp MH.
    Diabetes; 2008 Nov 10; 57(11):2977-91. PubMed ID: 18716045
    [Abstract] [Full Text] [Related]

  • 12. Cannabinoid CB₁ receptor restrains accentuated activity of hypothalamic corticotropin-releasing factor and brainstem tyrosine hydroxylase neurons in endotoxemia-induced hypophagia in rats.
    Rorato R, Reis WL, de Carvalho Borges B, Antunes-Rodrigues J, Elias LL.
    Neuropharmacology; 2012 Jul 10; 63(1):154-60. PubMed ID: 22138163
    [Abstract] [Full Text] [Related]

  • 13. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
    Tam J, Godlewski G, Earley BJ, Zhou L, Jourdan T, Szanda G, Cinar R, Kunos G.
    Am J Physiol Endocrinol Metab; 2014 Feb 15; 306(4):E457-68. PubMed ID: 24381003
    [Abstract] [Full Text] [Related]

  • 14. Effect of the cannabinoid receptor-1 antagonist rimonabant on lipolysis in rats.
    Mølhøj S, Hansen HS, Schweiger M, Zimmermann R, Johansen T, Malmlöf K.
    Eur J Pharmacol; 2010 Nov 10; 646(1-3):38-45. PubMed ID: 20727879
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
    Zhang L, Lee NJ, Nguyen AD, Enriquez RF, Riepler SJ, Stehrer B, Yulyaningsih E, Lin S, Shi YC, Baldock PA, Herzog H, Sainsbury A.
    Diabetes Obes Metab; 2010 Jul 10; 12(7):591-603. PubMed ID: 20590734
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity.
    Jacobson LH, Commerford SR, Gerber SP, Chen YA, Dardik B, Chaperon F, Schwartzkopf C, Nguyen-Tran V, Hollenbeck T, McNamara P, He X, Liu H, Seidel HM, Jaton AL, Gromada J, Teixeira S.
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec 10; 384(6):565-81. PubMed ID: 21947251
    [Abstract] [Full Text] [Related]

  • 18. Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.
    Mathes CM, Ferrara M, Rowland NE.
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul 10; 295(1):R67-75. PubMed ID: 18448611
    [Abstract] [Full Text] [Related]

  • 19. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
    Patel KN, Joharapurkar AA, Patel V, Kshirsagar SG, Bahekar R, Srivastava BK, Jain MR.
    Can J Physiol Pharmacol; 2014 Dec 10; 92(12):975-83. PubMed ID: 25361428
    [Abstract] [Full Text] [Related]

  • 20. The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food.
    Dore R, Valenza M, Wang X, Rice KC, Sabino V, Cottone P.
    Addict Biol; 2014 Sep 10; 19(5):849-61. PubMed ID: 23587012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.